N. Wang

583 total citations · 1 hit paper
7 papers, 376 citations indexed

About

N. Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, N. Wang has authored 7 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in N. Wang's work include Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Esophageal and GI Pathology (3 papers). N. Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Esophageal and GI Pathology (3 papers). N. Wang collaborates with scholars based in Sweden, Norway and Netherlands. N. Wang's co-authors include Lars Lundell, Magnus Nilsson, Signe Friesland, Jon A. Tsai, Nils Glenjen, Gjermund Johnsen, P Lind, Anne-Birgitte Jacobsen, Ingunn Hatlevoll and Fredrik Klevebro and has published in prestigious journals such as Annals of Oncology, Human Pathology and Cytometry.

In The Last Decade

N. Wang

7 papers receiving 371 citations

Hit Papers

A randomized clinical trial of neoadjuvant chemotherapy v... 2016 2026 2019 2022 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Wang Sweden 7 308 303 52 33 33 7 376
Katsu Hirayama Japan 7 256 0.8× 275 0.9× 49 0.9× 53 1.6× 13 0.4× 21 358
Masaki Arimori Japan 6 395 1.3× 425 1.4× 82 1.6× 30 0.9× 33 1.0× 12 487
Zhongsheng Lu China 12 238 0.8× 245 0.8× 44 0.8× 32 1.0× 170 5.2× 31 376
Chiemi Nakayama Japan 8 191 0.6× 230 0.8× 22 0.4× 35 1.1× 130 3.9× 11 335
Marie Washio Japan 10 181 0.6× 139 0.5× 56 1.1× 70 2.1× 56 1.7× 37 278
Marjolein Sikkema Netherlands 4 269 0.9× 387 1.3× 36 0.7× 19 0.6× 80 2.4× 10 417
Reiki Eguchi Japan 8 268 0.9× 293 1.0× 53 1.0× 23 0.7× 16 0.5× 25 330
Pooja R. Rohatgi United States 8 311 1.0× 298 1.0× 65 1.3× 60 1.8× 49 1.5× 8 401
Nobuaki Nishimata Japan 4 120 0.4× 120 0.4× 24 0.5× 26 0.8× 40 1.2× 11 176
Alessia D’Ignazio Italy 9 155 0.5× 113 0.4× 42 0.8× 20 0.6× 96 2.9× 22 242

Countries citing papers authored by N. Wang

Since Specialization
Citations

This map shows the geographic impact of N. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Wang more than expected).

Fields of papers citing papers by N. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Wang. The network helps show where N. Wang may publish in the future.

Co-authorship network of co-authors of N. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of N. Wang. A scholar is included among the top collaborators of N. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Wang. N. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Detlefsen, Sönke, Fátima Carneiro, James Conner, et al.. (2020). Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey. Human Pathology. 108. 60–67. 13 indexed citations
2.
Johnsen, Gjermund, Nils Glenjen, Signe Friesland, et al.. (2018). Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial. Diseases of the Esophagus. 32(2). 11 indexed citations
3.
Klevebro, Fredrik, Gabriella Alexandersson von Döbeln, N. Wang, et al.. (2016). A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Annals of Oncology. 27(4). 660–667. 273 indexed citations breakdown →
4.
Kumagai, Koshi, Lars Lundell, Jon A. Tsai, et al.. (2015). Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction. Diseases of the Esophagus. 29(5). 442–447. 23 indexed citations
5.
Nilsson, Anders, Florin Sirzén, Rolf Lewensohn, N. Wang, & Sven Skog. (1999). Cell cycle‐dependent regulation of the DNA‐dependent protein kinase. Cell Proliferation. 32(4). 239–248. 16 indexed citations
6.
Fosså, Sophie D., Aasmund Berner, Håkon Wæhre, et al.. (1992). DNA ploidy in cell nuclei from paraffin‐embedded material–comparison of results from two laboratories. Cytometry. 13(4). 395–403. 16 indexed citations
7.
Wang, N., Björn Stenkvist, & B. Tribukait. (1992). Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy.. PubMed. 14(3). 210–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026